Cargando…

COVID-19 and Obesity: Epidemiology, Pathogenesis and Treatment

The growing prevalence of overweight and obesity has been a worldwide public health issue. During the COVID-19 pandemic, obesity is associated with a higher risk of severity and a worse clinical outcome of SARS-COV-2 infection. This may be because of the chronic low-grade inflammation, impaired immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xinyu, Yang, Liu, Huang, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753883/
https://www.ncbi.nlm.nih.gov/pubmed/33363393
http://dx.doi.org/10.2147/DMSO.S285197
_version_ 1783626078814732288
author Zhu, Xinyu
Yang, Liu
Huang, Kai
author_facet Zhu, Xinyu
Yang, Liu
Huang, Kai
author_sort Zhu, Xinyu
collection PubMed
description The growing prevalence of overweight and obesity has been a worldwide public health issue. During the COVID-19 pandemic, obesity is associated with a higher risk of severity and a worse clinical outcome of SARS-COV-2 infection. This may be because of the chronic low-grade inflammation, impaired immune response and metabolic disorders in obese patients. In this narrative review, we have summarized the association between obesity and COVID-19 and discussed the potential pathogenesis and treatment in these patients. This work may provide practical suggestions on the clinical management of obese COVID-19 patients.
format Online
Article
Text
id pubmed-7753883
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-77538832020-12-23 COVID-19 and Obesity: Epidemiology, Pathogenesis and Treatment Zhu, Xinyu Yang, Liu Huang, Kai Diabetes Metab Syndr Obes Review The growing prevalence of overweight and obesity has been a worldwide public health issue. During the COVID-19 pandemic, obesity is associated with a higher risk of severity and a worse clinical outcome of SARS-COV-2 infection. This may be because of the chronic low-grade inflammation, impaired immune response and metabolic disorders in obese patients. In this narrative review, we have summarized the association between obesity and COVID-19 and discussed the potential pathogenesis and treatment in these patients. This work may provide practical suggestions on the clinical management of obese COVID-19 patients. Dove 2020-12-14 /pmc/articles/PMC7753883/ /pubmed/33363393 http://dx.doi.org/10.2147/DMSO.S285197 Text en © 2020 Zhu et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Zhu, Xinyu
Yang, Liu
Huang, Kai
COVID-19 and Obesity: Epidemiology, Pathogenesis and Treatment
title COVID-19 and Obesity: Epidemiology, Pathogenesis and Treatment
title_full COVID-19 and Obesity: Epidemiology, Pathogenesis and Treatment
title_fullStr COVID-19 and Obesity: Epidemiology, Pathogenesis and Treatment
title_full_unstemmed COVID-19 and Obesity: Epidemiology, Pathogenesis and Treatment
title_short COVID-19 and Obesity: Epidemiology, Pathogenesis and Treatment
title_sort covid-19 and obesity: epidemiology, pathogenesis and treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753883/
https://www.ncbi.nlm.nih.gov/pubmed/33363393
http://dx.doi.org/10.2147/DMSO.S285197
work_keys_str_mv AT zhuxinyu covid19andobesityepidemiologypathogenesisandtreatment
AT yangliu covid19andobesityepidemiologypathogenesisandtreatment
AT huangkai covid19andobesityepidemiologypathogenesisandtreatment